GeneDx Holdings Corp
NASDAQ:WGS

Watchlist Manager
GeneDx Holdings Corp Logo
GeneDx Holdings Corp
NASDAQ:WGS
Watchlist
Price: 80.78 USD -2.91% Market Closed
Market Cap: 2.2B USD
Have any thoughts about
GeneDx Holdings Corp?
Write Note

GeneDx Holdings Corp
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

GeneDx Holdings Corp
Operating Income Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
GeneDx Holdings Corp
NASDAQ:WGS
Operating Income
-$170.2m
CAGR 3-Years
11%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Operating Income
$1.8B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
0%
Quest Diagnostics Inc
NYSE:DGX
Operating Income
$1.3B
CAGR 3-Years
-20%
CAGR 5-Years
2%
CAGR 10-Years
3%
CVS Health Corp
NYSE:CVS
Operating Income
$12.9B
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
4%
Cigna Corp
NYSE:CI
Operating Income
$9.6B
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
12%
Laboratory Corporation of America Holdings
NYSE:LH
Operating Income
$1.1B
CAGR 3-Years
-34%
CAGR 5-Years
-4%
CAGR 10-Years
2%

See Also

What is GeneDx Holdings Corp's Operating Income?
Operating Income
-170.2m USD

Based on the financial report for Dec 31, 2023, GeneDx Holdings Corp's Operating Income amounts to -170.2m USD.

What is GeneDx Holdings Corp's Operating Income growth rate?
Operating Income CAGR 5Y
-43%

Over the last year, the Operating Income growth was 75%. The average annual Operating Income growth rates for GeneDx Holdings Corp have been 11% over the past three years , -43% over the past five years .

Back to Top